E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression
Open Access
- 26 March 2026
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 186
Abstract
WD repeat and HMG-box DNA-binding protein 1 (WDHD1) has been identified as a crucial oncogene in various tumors, but its role in pancreatic cancer remains unexplored. This study investigated the mechanisms by which WDHD1 contributes to pancreatic cancer progression. Differential analysis of the Cancer Genome Atlas (TCGA) pancreatic cancer samples identified abnormally expressed genes. Cellular assays, including cell proliferation, flow cytometry, and apoptosis assays, demonstrated WDHD1’s oncogenic role. WDHD1 expression was significantly elevated in pancreatic cancer cells and tissues compared to normal counterparts. Knockdown of WDHD1 inhibited cell proliferation, induced apoptosis, and caused G1-phase cell-cycle arrest. In vivo xenograft models further validated that WDHD1 knockdown suppressed the growth of pancreatic cancer cells. Mechanistically, WDHD1 knockdown resulted in significant reductions in CDK4 and cyclin D1 protein levels, whereas WDHD1 overexpression produced the opposite effects. Additionally, E2F1 overexpression increased the expression of WDHD1 at both mRNA and protein levels. Rescue experiments revealed that WDHD1 knockdown could reverse the E2F1-induced upregulation of CDK4 and cyclin D1 protein levels. In conclusion, E2F1 promotes pancreatic cancer cell proliferation and cell-cycle progression by upregulating WDHD1, which in turn enhances the expression of the CDK4–cyclin D1 complex.Keywords
Funding Information
- Science and Technology Support Programs of Sichuan Province (2025ZNSFSC1901)
- Science and Technology Support Programs of Sichuan Province (2026NSFSC1950)
- Postdoctoral Research Funds of West China Hospital, Sichuan University (2025HXBH050)
- Postdoctoral Research Funds of West China Hospital, Sichuan University (2025HXBH103)
- Peak Discipline Operation Fund of West China Hospital (GFYX25004)
- State-Owned Assets Supervision and Administration Commission Program C (GZC20251423)
This publication has 42 references indexed in Scilit:
- COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinomaBiochimica et Biophysica Acta (BBA) - General Subjects, 2024
- A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)Biomedicine & Pharmacotherapy, 2024
- Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancerCancer Letters, 2024
- Disorders of cancer metabolism: The therapeutic potential of cannabinoidsBiomedicine & Pharmacotherapy, 2022
- Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinomaActa Pharmaceutica Sinica B, 2022
- Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancerCancer Letters, 2022
- Discovery and characterization of potent And‐1 inhibitors for cancer treatmentClinical and Translational Medicine, 2021
- Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039International Journal of Cancer, 2021
- Targeting cell-cycle machinery in cancerCancer Cell, 2021
- Estimated Projection of US Cancer Incidence and Death to 2040JAMA Network Open, 2021